作者: David Duane Pfizer Global R. D. Thompson , Andrew George Pfizer Global R. D. Lee , Wesley Warren Pfizer Global R. D. Day
DOI:
关键词:
摘要: This invention relates to the use of estrogen agonists / antagonists for manufacture medicaments treatment conditions that are responsive elevation testosterone levels in body. The compositions comprised an agonist antagonist and a pharmaceutically acceptable vehicle, carrier or diluent. These effective treating male subject sexual dysfunction timidity female subjects including post-menopausal women increasing libido women. In case dysfunction, may also include compound which is elevator cyclic guanosine 3',5'-monophosphate (cGMP). Additionally, other whose etiology result deficiency can be ameliorated by within Uses according such as increase uses while substantially reducing concomitant liability adverse effects associated with administration.